MAINE MEDICAL CENTER RES INSTITUTE has a total of 12 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MEMORIAL SLOAN KETTERING CANCER CENTER, VACCIBODY AS and HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINI OF HEALTH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Diagnosis and surgery | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Contois Liangru | 6 |
#2 | Caron Jennifer M | 6 |
#3 | Brooks Peter C | 6 |
#4 | Brown Aaron C | 2 |
#5 | Maciag Thomas | 2 |
#6 | Soldi Raffaella | 1 |
#7 | Prudovsky Igor | 1 |
#8 | Drohan William N | 1 |
#9 | Ettenson David S | 1 |
#10 | Lindner Volkhard | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019140151A1 | Methods, compositions, and kits for producing beige adipocytes and treating metabolic disorders | |
WO2018075707A1 | Electrically controllable surgical tools | |
US2017240638A1 | Enhancing the therapeutic activity of immune checkpoint inhibitor | |
US2017065716A1 | Enhancing the therapeutic activity of an immune checkpoint inhibitor | |
AU2002364727A1 | Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 | |
AU2002329872B2 | Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |